Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Comparison of OK-432 and Doxycycline Pleurodesis for Malignant Pleural Effusions Caused by Lung Cancer

폐암에 의한 악성 흉막삼출환자에서 OK-432와 Doxycycline 흉막유착술의 비교

  • Chung, Jae-Ho (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Park, Moo-Suk (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Cheong, Jae-Hee (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Young-Sam (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Chang, Joon (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Joo-Hang (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kwak, Seung-Min (Department of Internal Medicine, College of Medicine, Inha University) ;
  • Kim, Sung-Kyu (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Se-Kyu (Department of Internal Medicine, Yonsei University College of Medicine)
  • 정재호 (연세대학교 의과대학 내과학교실) ;
  • 박무석 (연세대학교 의과대학 내과학교실) ;
  • 정재희 (연세대학교 의과대학 내과학교실) ;
  • 김영삼 (연세대학교 의과대학 내과학교실) ;
  • 장준 (연세대학교 의과대학 내과학교실) ;
  • 김주항 (연세대학교 의과대학 내과학교실) ;
  • 곽승민 (인하대학교 의과대학 내과학교실) ;
  • 김성규 (연세대학교 의과대학 내과학교실) ;
  • 김세규 (연세대학교 의과대학 내과학교실)
  • Published : 2002.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background : Lung cancer is the leading cause of malignant pleural effusions, which is currently most commonly treated using pleurodesis via bedside thoracostomy. Several agents had been used for the treatment of pleural sclerosis, but with differing efficacies and associated side effects. Our purpose with this study was to compare the efficacy, side effects and disease free survival times of patients being treated with OK-432 and doxycycline sclerotherapy in lung cancer induced malignant pleureal effusions. Materials and Methods : 79 patients who underwent pleurodesis with OK-432 and doxycycline, between Jan.1994 and Aug. 2001, were retrospectively reviewed. Response 30 days following pleurodesis were determined from chest radiographs, with the disease free survival time being evaluated according to the response. Results : The success rates, 30 day followint pleurodesis, with OK-432 and doxycycline 83 and 87%, respectively (p=0.677). With regard to the side effects, fever was more common when OK-432 was used (59%, p=0.001), and pain was more common with doxycycline use (73%, p=0.008). There was no significant difference in disease free survival times between OK-432 (13.6 Months) and doxycycline (11.6 Months) (p=0.532). Conclusion : with the use of OK-432, for pleurodesis, was as effective as doxycycline, can be considered as an alternative treatment for malignant effusion in patients with lung cancer.

목 적 : 폐암은 악성 흉막 삼출액의 가장 흔한 원인으로 흉관 삽입후 흉막유착술을 시행하는 것이 치료에 널리 이용 되어왔다. 흉막경화제는 여러 종류가 알려져 있으나 그 효과나 부작용은 약제마다 차이가 있다. 이에 저자들은 대표적 흉막경화제인 doxycycline과 새로운 약제인 OK-432의 효과, 부작용 및 무병기간의 차이를 알아보기 위해 본 연구를 시행하였다. 방 법 : 1994년 1월부터 2001년 8월까지 흉막천자 세포진검사 혹은 흉막조직검사상 악성 흉막염이 확인된 폐암환자 중 OK-432나 doxycycline으로 흉막유착술을 시행한 79명의 환자에게서 흉막 유착술 후 30일째의 성공률을 조사하였으며, 약제의 부작용과 무병 생존기간을 후향적으로 조사하였다. 결 과 : OK-432와 doxycycline을 이용한 흉막유착술 후 30일째의 성공률은 각각 83%와 87%으로 유의한 차이가 없었으며 (p=0.677), 부작용으로 발열은 OK-432군 (59%, p=0.001)에서 유의하게 많았고, 통증은 doxycycline군 (73%, p=0.008)에서 유의하게 많았다 무병기간은 두 군 사이에 유의한 차이가 없었다(OK-432 : 13.6개월, doxycycline : 11.6개월)(p=0.532). 결 론 : 폐암으로 인한 악성 흉막액을 치료하는 OK-432는 doxycycline과 비슷한 흉막유착술치료 효과가 있을 것으로 생각된다.

Keywords